Wenzel Spine announced FDA 510(k) clearance for their primaLOK SP spinal fusion technology. New clinical indications allow for primaLOK SP to be used at multiple levels and to treat patients with lumbar spinal stenosis.
Key features and benefits of primaLOK SP include:
A locking mechanism that ensures secure stabilization, reducing the risk of migration and providing stability during the critical fusion process.
Flexibility to accommodate various patient anatomies and offer surgeons the ability to tailor each procedure to individual needs.
A minimally invasive approach to minimize tissue disruption, potentially leading to reduced postoperative pain, shorter hospital stays and quicker patient recovery.
Enhanced radiographic visibility, allowing surgeons to assess implant placement and fusion progress.
Wenzel Spine announced FDA 510(k) clearance for their primaLOK SP spinal fusion technology. New clinical indications allow for primaLOK SP to be used at multiple levels and to treat patients with lumbar spinal stenosis.
Key features and benefits of primaLOK SP include:
A locking mechanism that ensures secure stabilization, reducing the...
Wenzel Spine announced FDA 510(k) clearance for their primaLOK SP spinal fusion technology. New clinical indications allow for primaLOK SP to be used at multiple levels and to treat patients with lumbar spinal stenosis.
Key features and benefits of primaLOK SP include:
A locking mechanism that ensures secure stabilization, reducing the risk of migration and providing stability during the critical fusion process.
Flexibility to accommodate various patient anatomies and offer surgeons the ability to tailor each procedure to individual needs.
A minimally invasive approach to minimize tissue disruption, potentially leading to reduced postoperative pain, shorter hospital stays and quicker patient recovery.
Enhanced radiographic visibility, allowing surgeons to assess implant placement and fusion progress.
Copy to clipboard 
